Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments

In this study we utilized data on patient responses to guided treatments, and we evaluated their benefit for a non-small cell lung cancer cohort. The recommended therapies used were predicted using tumor molecular profiles that involved a range of biomarkers but primarily used immunohistochemistry m...

Descripción completa

Detalles Bibliográficos
Autores principales: Alifrangis, Costi, Carter, Philip, Cereser, Biancastella, Chandrasinghe, Pramodh, Belluz, Lisa Del Bel, Lim, Eric, Moderau, Nina, Poyia, Fotini, Tabassum, Neha, Zhang, Hua, Krell, Jonathan, Stebbing, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849175/
https://www.ncbi.nlm.nih.gov/pubmed/29560111
http://dx.doi.org/10.18632/oncotarget.24375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849175/
https://www.ncbi.nlm.nih.gov/pubmed/29560111
http://dx.doi.org/10.18632/oncotarget.24375

Ejemplares similares